We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SCHERING-PLOUGH LAUNCHES GENERIC VERSION OF ITS OWN PRODUCT
SCHERING-PLOUGH LAUNCHES GENERIC VERSION OF ITS OWN PRODUCT
April 9, 2004
In a move that could undercut generics already on the market, drugmaker Schering-Plough last week launched a generic version of its own hepatitis C drug Rebetol (ribavirin) at what some analysts expect will be a steeply discounted price.